Key result
In a study of 871 women, five prothrombotic gene polymorphisms were not significantly associated with the development of pre-eclampsia or gestational hypertension.
Why the study?
Are prothrombotic gene polymorphisms associated with the development of pre-eclampsia or gestational hypertension in women?
Case-Control (n=871)
Are prothrombotic gene polymorphisms associated with the development of pre-eclampsia or gestational hypertension in women?
Answers are grounded in this paper and cite their sources.
Prothrombotic genotypes are not associated with the development of pre-eclampsia or gestational hypertension, suggesting little value in antenatal screening for these polymorphisms.
DNA samples collected as part of a large population-based case-control study were genotyped to examine the associations of five prothrombotic gene polymorphisms with pre-eclampsia (PE) and gestational hypertension (GH). The polymorphisms studied were: G1691A in Factor V (Factor V Leiden; FVL), prothrombin G20210A, methylenetetrahydrofolate reductase (MTHFR) C677T, plasminogen activator inhibitor-1 4G/5G and the platelet collagen receptor alpha2beta1 C807T. A group of 404 women who developed PE were retrospectively compared with 303 women with GH and 164 control women. The frequency of genotypes did not differ significantly between cases of PE or GH and controls for any of the five polymorphisms studied. We conclude that these prothrombotic genotypes are not associated with the development of PE or GH in our population. The systematic review supports our conclusion, for all but cases of severe disease. which appear to be associated with FVL and, to a lesser extent, MTHFR C677T. There is little value in antenatal screening for prothrombotic polymorphisms to predict the development of pre-eclampsia or gestational hypertension.
No takes yet. Share an insight, caveat, or question.
Morrison et al. (2002) conducted a case-control in Pre-eclampsia and gestational hypertension (n=871). Prothrombotic gene polymorphisms vs. Control women was evaluated on Pre-eclampsia and gestational hypertension. In a study of 871 women, five prothrombotic gene polymorphisms were not significantly associated with the development of pre-eclampsia or gestational hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: